Intapp (NASDAQ:INTA – Get Free Report) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday. INTA has been the topic of several other research reports. Piper Sandler decreased their target price on Intapp from $33.00 to $25.00 and set a “neutral” rating on […]

SCWorx (NASDAQ:WORX – Get Free Report) was upgraded by equities researchers at Wall Street Zen to a “hold” rating in a note issued to investors on Saturday. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SCWorx in a research report on Wednesday, January 21st. One analyst has rated the stock with a […]

HealthEquity (NASDAQ:HQY – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday. HQY has been the subject of a number of other reports. Barrington Research cut their price objective on HealthEquity from $125.00 to $110.00 and set an […]

NetApp (NASDAQ:NTAP – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday. Other analysts also recently issued research reports about the company. Weiss Ratings downgraded NetApp from a “buy (b-)” rating to a “hold (c+)” rating in a […]

SunCar Technology Group (NASDAQ:SDA – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a note issued to investors on Saturday. Several other analysts also recently commented on SDA. Zacks Research upgraded SunCar Technology Group to a “hold” rating in a research note on Wednesday, March 18th. […]

Cue Biopharma (NASDAQ:CUE – Get Free Report) was upgraded by research analysts at Wall Street Zen to a “buy” rating in a report issued on Saturday. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cue Biopharma in a research report on Friday, March 27th. One investment analyst has rated the stock with […]

Insight Enterprises (NASDAQ:NSIT – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Sunday. A number of other research firms have also weighed in on NSIT. Canaccord Genuity Group set a $90.00 price target on shares of […]

AtriCure (NASDAQ:ATRC – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Sunday. A number of other equities analysts have also recently issued reports on ATRC. JPMorgan Chase & Co. cut AtriCure from an “overweight” rating […]

Sharps Technology (NASDAQ:STSS – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sharps Technology in a research report on Thursday, January […]

Actuate Therapeutics (NASDAQ:ACTU – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Actuate Therapeutics in a research report on Friday, March 27th. Three […]

Smithfield Foods (NASDAQ:SFD – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Sunday. Other equities analysts have also recently issued reports about the stock. Zacks Research upgraded shares of Smithfield Foods from a “hold” rating to […]

Spero Therapeutics (NASDAQ:SPRO – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a research report issued on Sunday. Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Spero Therapeutics in a research report on Thursday, January 22nd. One analyst has […]